Any medical condition, or possible contraindication to donation, elicited at any point during the donation process, must be managed as indicated in the A - Z Topic section of these guidelines. Any collected material, which as a result is unsuitable for clinical use, must be clearly labelled as unfit for use.
If there is more than one contraindication to donation, any indicating the need to permanently defer the donor must be applied. This will mean that the donor is withdrawn from the donor panel. If withdrawal is not required, then the longest applicable deferral period must be applied.
Donors who undergo component donation procedures may be subject to additional or separate criteria compared to whole blood donors. Reference should be made to Chapter 3 Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood) of the Guidelines for the Blood Transfusion Services in the United Kingdom, 8th Edition, 2013.
Any new health risks identified by this process should be notified to the Standing Advisory Committee on Care and Selection of Donors, so that they can be considered for incorporation into future revisions of these guidelines.
Donations must not be accepted from donors who exhibit health risks that are not listed in this guidance, without referral to, and acceptance by, the Designated Clinical Support Officer.
This section was last updated in WB-DSG Edition 203, Release 20 Issue 01